Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Apolipoprotein E-epsilon 4 frequency in affective disorder

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Brain Changes Induced by Electroconvulsive Therapy Are Broadly Distributed

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Daily estimates of clinical severity of symptoms in bipolar disorder from smartphone-based self-assessments

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: The epsilon 4 allele of apolipoprotein E (APOE) as well as affective disorder have been found to be associated with Alzheimer's disease, but it is unclear whether cognitive impairment in affective disorder or subtypes of affective disorder is mediated by the epsilon 4 allele of APOE.

METHODS: The genotype of APOE was analyzed in 106 unipolar patients, 21 bipolar patients, and 46 controls and correlated with cognitive function in the euthymic phase as measured by the Mini-Mental State Examination, the Cambridge Cognitive Examination, the Mattis Dementia Rating Scale, the Gottfries-Bråne-Steen Dementia Rating Scale, and the Global Deterioration Scale.

RESULTS: The frequency of APOE-epsilon 4 allele was approximately the same in unipolar patients (.189) and in bipolar patients (.167). Although patients showed more cognitive impairment than controls, no significant overall difference was found between the frequency of APOE-epsilon 4 allele in patients (.185) and controls (.131). In fact, the frequency of APOE-epsilon 4 allele did not correlate with cognitive impairment. It was not possible to identify subgroups of patients with an increased frequency of APOE-epsilon 4 allele, as no association was found with gender, age at onset, the number of affective episodes, the presence of psychotic features, or the prevalence of familial affective disorder.

CONCLUSIONS: It seems that cognitive impairment in affective disorder can be attributed to pathways other than the APOE genotype.

Original languageEnglish
JournalBiological Psychiatry
Volume45
Issue number4
Pages (from-to)430-4
Number of pages5
ISSN0006-3223
Publication statusPublished - 15 Feb 1999

    Research areas

  • Adult, Apolipoprotein E4, Apolipoproteins E, Case-Control Studies, Chi-Square Distribution, Cognition Disorders, Cohort Studies, Denmark, Female, Gene Dosage, Humans, Likelihood Functions, Male, Mood Disorders, Journal Article, Research Support, Non-U.S. Gov't

ID: 53562557